<img src="https://secure.office-information-24.com/785669.png" style="display:none;">

David Orr, PhD, Medpoint, LLC

David Orr, PhD has spent nearly three decades leading engineering development, operations and product commercialization for medical device startups and global enterprises. As a prolific innovator of applied technologies, Dr. Orr has delivered products in oncology, renal, ophthalmology, cardiovascular and tissue engineering, resulting in 60+ issued patents and multiple therapeutic treatments and diagnostics. He also serves as an Adjunct Professor with Clemson’s Department of Bioengineering and co-authored book chapters on degradable biomaterials and three-dimensional cell culture. As CEO of Medpoint, LLC, Dr. Orr and their global team of professionals work with medical device and biopharmaceutical clients to support quality assurance, regulatory and clinical affairs initiatives. Dr. Orr earned a BS in Mechanical Engineering from Rose-Hulman Institute of Technology, an MBA from Purdue University's Krannert School of Management, and a PhD in Bioengineering from Clemson University.

Posts by David Orr, PhD, Medpoint, LLC

Deciphering the 483 Warning Letter: What Life Sciences Manufacturers Need to Know

Deciphering the 483 Warning Letter: What Life Sciences Manufacturers Need to Know

June 13, 2024 3 min read

Get the latest QT9 QMS blog articles delivered to your inbox.